N-[2,4-Dioxo-3-azatricyclo[7.3.1.0(5,13)]trideca-1(13),5,7,9,11-pentaen-3-yl]thiourea

被引：2

作者：

Al-Salahi, Rashad ^{[1
]}

Al-Omar, Mohamed ^{[1
]}

Marzouk, Mohamed ^{[1
]}

Ng, Seik Weng ^{[2
,3
]}

机构：

[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia

[2] Univ Malaya, Dept Chem, Kuala Lumpur 50603, Malaysia

[3] King Abdulaziz Univ, Fac Sci, Chem Dept, Jeddah, Saudi Arabia

来源：

ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS | 2012年 / 68卷

关键词：

D O I：

10.1107/S1600536812021812

中图分类号：

O7 [晶体学];

学科分类号：

0702 ; 070205 ; 0703 ; 080501 ;

摘要：

In the two independent molecules in the asymmetric unit of the title compound, C13H9N3O2S, the azatricyclotridecapentaene ring system is approximately planar with r.m.s. deviations of 0.022 and 0.033 angstrom. The urea unit connected to the fused rings is approximately perpendicular [dihedral angles = 82.4 (1) and 82.7 (1)degrees]. In the crystal, the molecules associate by N-H center dot center dot center dot O hydrogen bonds, forming a chain running along the a axis. The crystal studied was a non-merohedral twin with a fractional contribution of 49.6 (1)% for the minor domain.

引用

页码：O1811 / +

页数：9

共 5 条

[1]

[Anonymous], 2012, CRYSALIS PRO

[2]

Barbour L.J., 2001, J SUPRAMOL CHEM, V1, P189, DOI DOI 10.1016/S1472-7862(02)00030-8

[3] Discovery of Phthalimides as Immunomodulatory and Antitumor Drug Prototypes [J].